跳至主要内容
临床试验/EUCTR2004-003776-10-LV
EUCTR2004-003776-10-LV进行中(未招募)不适用

Safety amd tolerability of ocaperidone in the continuation treatment of patients with schizophrenia: a double-blind, parallel group, multicentre, fixed dose, follow-up study

euro3d0 个研究点目标入组 20 人开始时间: 2005年1月24日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - patients who completed study N3D/FOR-OCA-05;
  • - patients who are BPRS responders and tolerated treatment well in study N3D/FOR-OCA-05;
  • - patients must have given written informed consent prior to screening assessments;
  • - a legal representative (guardian or relative) can consent on behalf of the patient if he/she is unable to provide written consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - any patient who was never included in study N3D/FOR-OCA-05
  • - any patient who had a premature termination in prior study N3D/FOR-OCA-05 must not be included in N3D/FOR-OCA-08 study

研究者

发起方
euro3d

相似试验